glp 1 agonist in ckd GLP-1 receptor agonists and next-generation metabolic hormone therapies chronic kidney disease GLP-1 RAs, Other Agents, Underused
Description
Killion EA, Chen M, Falsey JR, Sivits G, Hager T, Atangan L, Helmering J, Lee J, Li H, Wu B, et al
However, additional studies are warranted to validate these findings (Varnum et al., 2023)
[DOI] [PMC free article] [PubMed] [Google Scholar] 133.Riddle MC, Forst T, Aronson R, Sauque-Reyna L, Souhami E, Silvestre L, Ping L, Rosenstock J
Hall KD, Kahan S
Lu SC, Chen M, Atangan L, et al
( Epub 2013/08/21 )
